// company-profile

Maze Therapeutics, Inc.

MAZEExchange: NasdaqSector: Biological Products, (No Diagnostic Substances)Inc.: DEFilings: 47Insiders: 22

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares versus 1 sale. Buying was led by Dandekar Atul.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Apr 29, 2026Dandekar AtulMAZESale7,500$25.37$190K
Apr 29, 2026Dandekar AtulMAZEOption Exercise7,500$10.42$78K
Apr 29, 2026Dandekar AtulMAZEOption Exercise7,500$0.00$0K
Apr 1, 2026Bachrodt AmyMAZEOption Exercise2,500$0.00$0K
Apr 1, 2026Bernstein HaroldMAZESale300$31.07$9K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →